KuoOffice's videos (36)


862
May 26, 2010
Module II - Section 4

Key Therapeutic Area: Neurology http://pharmacogenomics.ucsd.edu/

1103
May 26, 2010
Module II - Section 3

Key Therapeutic Area: Anticoaugulation http://pharmacogenomics.ucsd.edu/

876
May 26, 2010
Module II - Section 2

Key Therapeutic Area: Oncology http://pharmacogenomics.ucsd.edu/

935
May 26, 2010
Module II - Section 1

Key Therapeutic Area: Infectious Disease http://pharmacogenomics.ucsd.edu/

914
May 26, 2010
Module I - Section 5

Ethical Legal Social Issues http://pharmacogenomics.ucsd.edu/

821
May 26, 2010
Module I - Section 4

Patient Case 2 http://pharmacogenomics.ucsd.edu/

949
May 26, 2010
Module I - Section 3

Patient Case 1 http://pharmacogenomics.ucsd.edu/

918
May 26, 2010
Module I - Section 2

Pharmacogenomic Nomenclature

849
May 26, 2010
Module I - Section 1

Translating Pharmacogenomic Into Practice http://pharmacogenomics.ucsd.edu/

1787
Apr 21, 2010
A variant of the HTRA1 gene increases susceptibility to age-related macular...

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world...

780
Apr 14, 2010
Evaluation of an Educational Program for Women and Pharmacists on Safe Use of...

To increase the awareness of CTIS services for pharmacists and consumers

1654
Feb 16, 2010
Dr. Beatriz Lewis's Pharmacy Practice at UCSD's Moores Cancer Center

The San Diego Pharmacist Resource and Research Network is conducting a study to discover the best...

9283
Nov 23, 2009
PharmGenEd™ Principles and Concepts of Pharmacogenomics

The presentation is divided into several sections as outlined by the powerpoint slide. In this module we will...

3984
Nov 18, 2009
PharmGenEd: Clinical Application of Pharmacogenomics

We will review the use of pharmacogenomic tests in five therapeutic areas. Infectious disease Oncology...